GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (NAS:ALBT) » Definitions » EPS without NRI

Avalon Globocare (Avalon Globocare) EPS without NRI : $-1.61 (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Avalon Globocare EPS without NRI?

Avalon Globocare's earnings per share without non-recurring items for the three months ended in Dec. 2023 was $-0.97. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.61.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -0.60% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Avalon Globocare's EPS without NRI or its related term are showing as below:

ALBT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -83   Med: -0.6   Max: 22
Current: -0.6

During the past 10 years, Avalon Globocare's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 22.00% per year. The lowest was -83.00% per year. And the median was -0.60% per year.

ALBT's 3-Year EPS without NRI Growth Rate is ranked worse than
55.64% of 1233 companies
in the Real Estate industry
Industry Median: 4.9 vs ALBT: -0.60

Avalon Globocare's EPS (Diluted) for the three months ended in Dec. 2023 was $-0.90. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.57.

Avalon Globocare's EPS (Basic) for the three months ended in Dec. 2023 was $-0.90. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.57.


Avalon Globocare EPS without NRI Historical Data

The historical data trend for Avalon Globocare's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare EPS without NRI Chart

Avalon Globocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.53 -1.60 -1.07 -1.20 -1.63

Avalon Globocare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.28 -0.21 -0.15 -0.97

Competitive Comparison of Avalon Globocare's EPS without NRI

For the Real Estate Services subindustry, Avalon Globocare's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avalon Globocare's PE Ratio without NRI Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, Avalon Globocare's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Avalon Globocare's PE Ratio without NRI falls into.



Avalon Globocare EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avalon Globocare  (NAS:ALBT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Avalon Globocare EPS without NRI Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Avalon Globocare (Avalon Globocare) Business Description

Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Executives
Lourdes Felix director 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
W J Tauzin director 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Wenzhao Lu director, 10 percent owner C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Andrew Sanders director 431 EAST 20TH STREET, NEW YORK NY 10010
Yancen Lu director 14009 SE 50TH STREET, BELLEVUE WA 98006
Stilley William B. Iii director 1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE VA 22901
Tevi Troy director 611 SOMERSWORTH WAY, SILVER SPRING MD 20902
Luisa Ingargiola officer: Chief Financial Officer 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
David Jin director, officer: CEO and President C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Yue Charles Li director C/O AVALON GLOBOCARE CORP., 4400 ROUTE 9 SOUTH, SUITE 3100, FREEHOLD NJ 07728
Meng Li director, officer: Chief Operating Officer C/O GLOBAL TECHNOLOGIES CORP., 3 SOUTH STREET, SUITE 101, FREEHOLD NJ 97728
Steven Philip Sukel director 33 ALPINE DRIVE, MORGANVILLE NJ 07751

Avalon Globocare (Avalon Globocare) Headlines

From GuruFocus

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

By GuruFocusNews GuruFocusNews 06-14-2022

Avalon GloboCare to Participate in the 35th Annual Roth Conference

By sperokesalga sperokesalga 03-03-2023

Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

By GuruFocusNews GuruFocusNews 06-04-2022